Episurf Medical receives reimbursement coverage for Episealer® Talus in Belgium
Episurf Medical (NASDAQ: EPIS B) today announces that reimbursement coverage has been established for the ankle technology, Episealer® Talus, in the Belgian market. The announcement follows a decision by the Insurance Committee of NIHDI (National Institute for Health and Disability Insurance), who has issued a positive decision for Episealer® Talus. The decision applies to both the private and the public markets in Belgium. ”We are continuing to make progress in all of our markets, and today’s announcement represents a critical step in our process of launching Episealer® Talus in the